Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma
2018 · Journal of Hepatology · 296 citations
https://doi.org/10.1016/j.jhep.2018.02.008
Y
Yanan Kong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
122
Papers
4.0K
Citations
33
h-index
54
i10-index
Yanan Kong is an academic researcher from Shihezi University. The author has contributed to research in topics: MicroRNA in disease regulation & Cancer-related molecular mechanisms research & Breast Cancer Treatment Studies. The author has an h-index of 33, co-authored 104 publications.
ORCID: 0000-0002-3145-5492Papers by this author
worksN6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer
2022 · Nature Communications · 211 citations
https://doi.org/10.1038/s41467-022-30217-7
Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22
2013 · Cancer Letters · 120 citations
https://doi.org/10.1016/j.canlet.2013.06.027
Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer
2012 · Medical Oncology · 77 citations
https://doi.org/10.1007/s12032-012-0260-6
Ablation Reboots the Response in Advanced Hepatocellular Carcinoma With Stable or Atypical Response During PD-1 Therapy: A Proof-of-Concept Study
2020 · Frontiers in Oncology · 55 citations
https://doi.org/10.3389/fonc.2020.580241
LGR6 Promotes Tumor Proliferation and Metastasis through Wnt/β-Catenin Signaling in Triple-Negative Breast Cancer
2020 · Molecular Therapy — Oncolytics · 40 citations
https://doi.org/10.1016/j.omto.2020.06.020
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat